Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Heron Therapeutics Inc.
Headquarters: San Diego, CA, United States of America
Website: http://www.herontx.com
Year Founded: 1983
Status: Public
Industry Sector: HealthTechnology
CEO: Craig A. Collard
Number Of Employees: 122
Enterprise Value: $351,726,970
PE Ratio: -23.96
Exchange/Ticker 1: NASDAQ:HRTX
Exchange/Ticker 2: N/A
Latest Market Cap: $339,695,904
BioCentury | Jun 14, 2024
Management Tracks
Connect leans into its U.S. profile as it remakes its leadership
Plus: Medivation vet Hung now chair of T-Therapeutics and updates from Voyager and Eyenuk
BioCentury | Apr 4, 2024
Management Tracks
Upstream names new CEO, CFO and COO
Plus: Acadia hires Elizabeth Thompson as head of R&D, and updates from Insitro, Fractyl, Adarx and more
BioCentury | Feb 1, 2024
Management Tracks
Rhodes, Manhard join Acadia
Plus: Vivodyne hires Menschik as CTO and an update from Enhanc3D
BioCentury | Jan 6, 2024
Data Byte
10 more PDUFA dates in January following year’s first FDA approval
Upcoming decisions include Astellas’ zolbetuximab, the first CLDN18.2 mAb up for approval
BioCentury | Jun 26, 2023
Management Tracks
Charl van Zyl to succeed Dunsire at Lundbeck
Plus: Raj Kannan named CEO at I-Mab, and updates from uniQure, Immodulon, Ichnos and more
BioCentury | Jun 13, 2023
Management Tracks
CEO Francis deSouza Illumina's second major departure in weeks
Plus: Denner among those departing Biogen’s board, and updates from the White House, Delix, Heron and more
BioCentury | Apr 20, 2023
Management Tracks
Abata hires Leonard Dragone as CMO
Plus: Amylyx gets a head of international markets, and updates from Heron, Breye, Alvotech and more
BioCentury | Apr 3, 2023
Management Tracks
Vounatsos, Maraganore to advise Legend
Plus: Kawakami becomes president of Mitsubishi’s U.S. unit and updates from InCarda,
BioCentury | Oct 12, 2022
Management Tracks
Wiggins, Simon join C-suite at Vaxcyte
Plus AZ’s Sheldon joining GSK (at last) and updates from Sudo, Walden, 1910 and more
BioCentury | Sep 3, 2022
Data Byte
At least 8 PDUFA dates on deck in September
Three submissions are under FDA priority review
Items per page:
1 - 10 of 67